Summit Therapeutics, Inc.
Executive Director, Analytical Sciences
Summit Therapeutics, Inc., Princeton, New Jersey, us, 08543
Overview
About Summit
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. Summit believes in building a team of world-class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Location:
Princeton, NJ (on-site) Summary
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including in:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 study evaluating ivonescimab with chemotherapy versus placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 study evaluating ivonescimab with chemotherapy versus pembrolizumab with chemotherapy in first-line metastatic NSCLC.
HARMONi-7: Phase 3 study evaluating ivonescimab monotherapy versus pembrolizumab monotherapy in first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 study evaluating ivonescimab in combination with chemotherapy versus bevacizumab with chemotherapy.
Ivonescimab is an investigational therapy not presently approved by regulatory authorities other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, with additional offices in California, New Jersey, the UK, and Ireland.
Role And Responsibilities Executive Director, Analytical Sciences
will provide strategic and operational leadership for all analytical activities supporting the development, registration, and commercialization of the Company’s lead bispecific antibody product. With the first Biologics License Application (BLA) already submitted, this role is critical to ensuring regulatory compliance, product control, and lifecycle readiness as the organization transitions from late-stage development into commercial supply.
The successful candidate will be accountable for the end-to-end analytical control strategy, including method development, qualification, transfer, and oversight of GMP release and stability testing executed through a virtual network of CDMOs and partner laboratories. This individual will act as a key CMC leader and regulatory partner, interfacing closely with Quality, Manufacturing, Regulatory Affairs, and external collaborators.
Role And Responsibilities
Analytical Strategy & Product Control
Own and continuously evolve the global analytical control strategy for clinical and commercial drug substance and drug product.
Ensure analytical readiness to support BLA review, responses to regulatory questions, inspections, and post-approval commitments.
Define analytical lifecycle management strategies aligned with ICH Q2/Q6/Q12 and global regulatory expectations.
Method Development, Qualification & Transfer
Provide oversight and scientific leadership for method development and optimization, qualification and validation, and method transfer to internal and external laboratories.
Ensure analytical methods are phase-appropriate, robust, stability-indicating, and fit for commercial use.
Troubleshoot complex analytical issues related to bispecific antibodies (e.g., heterogeneity, potency, binding, impurities).
GMP Release & Stability Oversight
Accountable for all drug substance and drug product release and stability testing conducted at external CDMOs and partner labs.
Ensure compliance with cGMP, data integrity, and regulatory filing requirements.
Review and approve analytical protocols, reports, deviations, OOS/OOT investigations, and change controls.
CDMO & Partner Management
Lead analytical governance across a virtual network of CDMOs, contract labs, and development partners.
Set expectations, KPIs, and quality standards for external analytical execution.
Serve as the primary analytical escalation point for CDMO performance, compliance, and technical issues.
Regulatory Support
Act as the analytical subject-matter expert for global regulatory interactions.
Author, review, and approve analytical sections of BLAs, MAAs, and IND/IMPD amendments, regulatory responses and briefing packages.
Support regulatory inspections, audits, and health authority meetings.
Cross-Functional Leadership
Partner closely with Process Development, Manufacturing, Quality, Regulatory Affairs, and Supply Chain.
Contribute to overall CMC strategy, risk management, and commercialization planning.
Build scalable analytical capabilities aligned with future pipeline expansion.
Experience, Education And Specialized Knowledge And Skills
PhD in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, or a related field (MS with extensive relevant experience considered).
Experience
15+ years of progressive experience in analytical sciences within the biopharmaceutical industry
Demonstrated leadership in late-stage development and commercial biologics
Direct experience supporting BLA/MAA submissions and approvals
Strong expertise in monoclonal and/or bispecific antibodies
Proven success operating within virtual or highly outsourced CMC models
Technical Expertise
Deep knowledge of physicochemical and functional characterization of biologics
Potency, binding, and cell-based assays
Stability programs and comparability strategies
Strong understanding of GMP, ICH, FDA, EMA, and global regulatory requirements
Experience managing analytical aspects of process changes, scale-up, and post-approval lifecycle management
Leadership & Competencies
Strategic thinker with a commercial mindset
Comfortable operating in ambiguity and fast-paced, resource-lean environments
Strong external partner and stakeholder management skills
Excellent written and verbal communication, including regulatory writing
Hands-on leader capable of balancing strategic oversight with technical depth
The pay range for this role is $260,000-$280,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
#J-18808-Ljbffr
About Summit
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. Summit believes in building a team of world-class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Location:
Princeton, NJ (on-site) Summary
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including in:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 study evaluating ivonescimab with chemotherapy versus placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 study evaluating ivonescimab with chemotherapy versus pembrolizumab with chemotherapy in first-line metastatic NSCLC.
HARMONi-7: Phase 3 study evaluating ivonescimab monotherapy versus pembrolizumab monotherapy in first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 study evaluating ivonescimab in combination with chemotherapy versus bevacizumab with chemotherapy.
Ivonescimab is an investigational therapy not presently approved by regulatory authorities other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, with additional offices in California, New Jersey, the UK, and Ireland.
Role And Responsibilities Executive Director, Analytical Sciences
will provide strategic and operational leadership for all analytical activities supporting the development, registration, and commercialization of the Company’s lead bispecific antibody product. With the first Biologics License Application (BLA) already submitted, this role is critical to ensuring regulatory compliance, product control, and lifecycle readiness as the organization transitions from late-stage development into commercial supply.
The successful candidate will be accountable for the end-to-end analytical control strategy, including method development, qualification, transfer, and oversight of GMP release and stability testing executed through a virtual network of CDMOs and partner laboratories. This individual will act as a key CMC leader and regulatory partner, interfacing closely with Quality, Manufacturing, Regulatory Affairs, and external collaborators.
Role And Responsibilities
Analytical Strategy & Product Control
Own and continuously evolve the global analytical control strategy for clinical and commercial drug substance and drug product.
Ensure analytical readiness to support BLA review, responses to regulatory questions, inspections, and post-approval commitments.
Define analytical lifecycle management strategies aligned with ICH Q2/Q6/Q12 and global regulatory expectations.
Method Development, Qualification & Transfer
Provide oversight and scientific leadership for method development and optimization, qualification and validation, and method transfer to internal and external laboratories.
Ensure analytical methods are phase-appropriate, robust, stability-indicating, and fit for commercial use.
Troubleshoot complex analytical issues related to bispecific antibodies (e.g., heterogeneity, potency, binding, impurities).
GMP Release & Stability Oversight
Accountable for all drug substance and drug product release and stability testing conducted at external CDMOs and partner labs.
Ensure compliance with cGMP, data integrity, and regulatory filing requirements.
Review and approve analytical protocols, reports, deviations, OOS/OOT investigations, and change controls.
CDMO & Partner Management
Lead analytical governance across a virtual network of CDMOs, contract labs, and development partners.
Set expectations, KPIs, and quality standards for external analytical execution.
Serve as the primary analytical escalation point for CDMO performance, compliance, and technical issues.
Regulatory Support
Act as the analytical subject-matter expert for global regulatory interactions.
Author, review, and approve analytical sections of BLAs, MAAs, and IND/IMPD amendments, regulatory responses and briefing packages.
Support regulatory inspections, audits, and health authority meetings.
Cross-Functional Leadership
Partner closely with Process Development, Manufacturing, Quality, Regulatory Affairs, and Supply Chain.
Contribute to overall CMC strategy, risk management, and commercialization planning.
Build scalable analytical capabilities aligned with future pipeline expansion.
Experience, Education And Specialized Knowledge And Skills
PhD in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, or a related field (MS with extensive relevant experience considered).
Experience
15+ years of progressive experience in analytical sciences within the biopharmaceutical industry
Demonstrated leadership in late-stage development and commercial biologics
Direct experience supporting BLA/MAA submissions and approvals
Strong expertise in monoclonal and/or bispecific antibodies
Proven success operating within virtual or highly outsourced CMC models
Technical Expertise
Deep knowledge of physicochemical and functional characterization of biologics
Potency, binding, and cell-based assays
Stability programs and comparability strategies
Strong understanding of GMP, ICH, FDA, EMA, and global regulatory requirements
Experience managing analytical aspects of process changes, scale-up, and post-approval lifecycle management
Leadership & Competencies
Strategic thinker with a commercial mindset
Comfortable operating in ambiguity and fast-paced, resource-lean environments
Strong external partner and stakeholder management skills
Excellent written and verbal communication, including regulatory writing
Hands-on leader capable of balancing strategic oversight with technical depth
The pay range for this role is $260,000-$280,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
#J-18808-Ljbffr